Physician

Richard F Lavi, M.D.

According to 2025 Medicare claims, Richard Lavi, M.D. (NPI: 1104857895) practices allergy/immunology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is ALLERGY ASTHMA & SINUS RELIEF CENTER INC (NPI: 1760716674; TIN: 264165151) and primary practice location at 44087-2387.

Lavi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 20,465 HCPCS/CPT codes, and received $378,265 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,349 prescription claims across 275 beneficiaries totaling $2,470,397 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 211 claims. Open Payments data shows 115 records totaling $6,247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $13,928 to $378,265. Similarly, Part D prescription costs have moved sharply higher in recent years, from $27,936 to $2,470,397. In contrast, DME billing represents a smaller volume and rose steadily, from $1,261 to $3,408.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	64	1,015	$13,928
2016	101	1,470	$34,629
2017	98	1,921	$30,117
2018	108	1,649	$23,052
2019	116	2,020	$22,962
2020	134	3,167	$37,141
2021	163	7,680	$166,834
2022	143	12,716	$267,936
2023	176	19,165	$364,385
2024	162	20,465	$378,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	357	$27,936
2016	93	366	$75,868
2017	106	421	$150,951
2018	140	540	$140,500
2019	161	736	$164,008
2020	205	1,018	$138,390
2021	259	1,230	$306,866
2022	274	1,433	$783,317
2023	282	1,468	$2,020,564
2024	275	1,349	$2,470,397

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	41	$1,149
2018	N/R	77	$32,036
2019	N/R	52	$18,844
2020	N/R	40	$17,132
2021	N/R	113	$98,286
2022	N/R	133	$138,989
2023	N/R	164	$211,544
2024	N/R	211	$310,096

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	33	33	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	117	$87
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	52	52	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	60	75	$64
94010	Test to measure expiratory airflow and volume	29	30	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	18	504	$930,078
Orladeyo	Berotralstat Hydrochloride	16	448	$707,682
Icatibant	Icatibant Acetate	15	423	$259,342
Dupixent Pen	Dupilumab	19	588	$84,369
Xolair	Omalizumab	13	308	$47,485

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	81	$252,519
J1576	Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$50,543
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	11	$3,626
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	45	$2,693
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	45	$463

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	115	$6,247	Pharming Healthcare, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard F. Lavi, M.D.?

Tedicare shows public-source Medicare data for Richard F. Lavi, M.D. (NPI 1104857895), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard F. Lavi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard F. Lavi, M.D.?

Richard F. Lavi, M.D. is linked to ALLERGY ASTHMA & SINUS RELIEF CENTER INC (billing NPI 1760716674) in the available physician profile data.

Does Richard F. Lavi, M.D. have Open Payments data?

Richard F. Lavi, M.D. has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.